Seasoned finance and operations executive with experience leading investment strategy, corporate development and portfolio company value creation in middle-market technology and services. Vickie Gutierrez combines hands-on operating leadership with experience structuring deals, capital raises and strategic partnerships, and has served in senior roles across growth-stage and PE-backed companies. Market-focused profile emphasizing operational turnarounds, margin improvement and scalable go-to-market execution; often active in board or advisory capacities supporting investor oversight. Relevant for investors seeking operators with cross-functional execution skills and deal execution experience.
Seasoned finance and operations executive with experience leading investment strategy, corporate development and portfolio company value creation in middle-market technology and services. Vickie Gutierrez combines hands-on operating leadership with experience structuring deals, capital raises and strategic partnerships, and has served in senior roles across growth-stage and PE-backed companies. Market-focused profile emphasizing operational turnarounds, margin improvement and scalable go-to-market execution; often active in board or advisory capacities supporting investor oversight. Relevant for investors seeking operators with cross-functional execution skills and deal execution experience.
Combines operator-first investing with pragmatic, value‑creation driven capital deployment focused on middle‑market technology and services. Prioritizes deals where operational turnarounds, margin expansion and scalable go‑to‑market playbooks can materially de‑risk growth; underwrites opportunities through hands‑on diligence, KPI‑led forecasting and focused capital for execution (buy‑and‑build, tuck‑ins, selective growth capital). Prefers medium-term horizons tied to execution milestones, active board or advisory involvement, tight cost and cash discipline, and partnerships that align management incentives with measurable operational milestones.
Combines operator-first investing with pragmatic, value‑creation driven capital deployment focused on middle‑market technology and services. Prioritizes deals where operational turnarounds, margin expansion and scalable go‑to‑market playbooks can materially de‑risk growth; underwrites opportunities through hands‑on diligence, KPI‑led forecasting and focused capital for execution (buy‑and‑build, tuck‑ins, selective growth capital). Prefers medium-term horizons tied to execution milestones, active board or advisory involvement, tight cost and cash discipline, and partnerships that align management incentives with measurable operational milestones.
| Trades 236 | Longs Won 172/236 72% | Profit Factor 6.05 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $193,940.85 |
| Average Win $74,048.78 | Best Trade (Oct 14) $2.05M | Sharpe Ratio -1,503.66 |
| Average Loss -$32,867.95 | Worst Trade (Oct 14) -$622,686.74 | Z-Score 6.81 (100%) |
| Commissions $0 | Avg. Trade Length 7m 1w 6d | Expectancy $43,721 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 3,413 | 3,072 | 2,730 | 2,389 | 2,048 | 1,706 | 1,365 | 1,024 | 683 | 341 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 6,714 | $1.71M | $2.3M | - | $595,141.99 | 34.81% | +0.089% |
ABBV AbbVie Inc. | 2,211 | $511,764.37 | $637,143.87 | - | $125,379.5 | 24.5% | +1.654% |
ABT Abbott Laboratories | 3,000 | $401,136.41 | $313,590 | - | -$87,546.41 | -21.82% | +1.515% |
AMAT Applied Materials, Inc. | 601 | $205,416 | $257,158.88 | - | $51,742.88 | 25.19% | -4.197% |
AMGN Amgen Inc. | 544 | $178,578.42 | $238,636.48 | - | $60,058.06 | 33.63% | +2.948% |
AMZN Amazon.com Inc | 4,084 | $895,288.51 | $1.03M | - | $139,352.05 | 15.57% | -0.291% |
BLK BlackRock, Inc. | 211 | $223,299 | $232,435.49 | - | $9,136.49 | 4.09% | +2.589% |
BRK-B Berkshire Hathaway Inc. | 898 | $451,460.93 | $474,512.1 | - | $23,051.17 | 5.11% | +0.391% |
BRO Brown & Brown Inc. | 6,585 | $563,181.33 | $448,043.4 | - | -$115,137.93 | -20.44% | +5% |
CL Colgate-Palmolive Company | 2,544 | $203,617.7 | $235,803.36 | - | $32,185.66 | 15.81% | -0.097% |
CLX The Clorox Company | 7,680 | $946,944 | $660,326.4 | - | -$286,617.6 | -30.27% | +1.189% |
CVS CVS Health Corporation | 3,000 | $226,170 | $275,340 | - | $49,170 | 21.74% | +1.538% |
CVX Chevron Corporation | 3,210 | $499,274.29 | $708,768 | - | $209,493.71 | 41.96% | -0.558% |
| EVMO EVMO | 112,993 | $5.72M | $5.73M | - | $11,479.62 | 0.2% | 0.0 |
EW Edwards Lifesciences Corporation | 3,010 | $234,861.46 | $258,920.2 | - | $24,058.74 | 10.24% | -0.497% |
FESM Fidelity Enhanced Small Cap ETF | 149,550 | $5.65M | $6.68M | - | $1.03M | 18.2% | +0.552% |
GLDM SPDR Gold MiniShares Trust | 37,124 | $2.85M | $3.04M | - | $194,921.71 | 6.84% | +1.072% |
GOOG Alphabet Inc | 3,392 | $828,791.38 | $1.17M | - | $338,531.5 | 40.85% | +0.143% |
GOOGL Alphabet Inc | 2,327 | $565,693.47 | $810,587.18 | - | $244,893.71 | 43.29% | +0.201% |
GPIX S&P 500 Core Premium Income Fund | 71,595 | $3.8M | $4.01M | - | $209,422.01 | 5.52% | +0.036% |